Gene: FAM168B
Official Full Name: family with sequence similarity 168 member Bprovided by HGNC
Gene Summary: Predicted to act upstream of or within axonogenesis and gene expression. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26644 | FAM168B Knockout cell line (HeLa) | Human | FAM168B | 1:3~1:6 | Negative | Online Inquiry |
KO26645 | FAM168B Knockout cell line (HCT 116) | Human | FAM168B | 1:2~1:4 | Negative | Online Inquiry |
KO26646 | FAM168B Knockout cell line (HEK293) | Human | FAM168B | 1:3~1:6 | Negative | Online Inquiry |
KO26647 | FAM168B Knockout cell line (A549) | Human | FAM168B | 1:3~1:4 | Negative | Online Inquiry |
FAM168B Gene Knockout Cell Lines are engineered cellular models specifically designed to facilitate the study of gene function, cellular processes, and disease mechanisms. Utilizing CRISPR/Cas9 technology, these cell lines have been derived to effectively disable the FAM168B gene, providing researchers with a powerful tool to investigate the role of this gene in various biological contexts, including cancer, neurodegenerative diseases, and cell signaling pathways.
The primary function of FAM168B is associated with cellular responses to DNA damage and repair processes. By creating knockout cell lines, the mechanisms by which FAM168B contributes to these pathways can be elucidated in a controlled environment. Researchers can evaluate phenotypic changes, assess cellular viability, and measure alterations in signaling cascades, thereby gaining crucial insights into how FAM168B dysfunction may lead to disease states.
The scientific significance of these knockout cell lines extends to both fundamental research and therapeutic application. They offer an essential platform for the discovery of novel drug targets, as well as for understanding the genomic underpinnings of various pathologies. In clinical settings, they can be employed to assess the efficacy of potential treatments and to personalize therapeutic strategies based on individual genetic profiles.
A key advantage of the FAM168B Gene Knockout Cell Lines is their specificity and reliability. Unlike generic knockdowns using RNA interference, which can have off-target effects, CRISPR-mediated knockouts provide precise gene disruption, ensuring that observed effects are directly attributable to the FAM168B gene. This specificity enhances the reproducibility of experiments and aids in the reliable interpretation of data.
For researchers and clinicians focused on the cellular basis of disease, the introduction of FAM168B Gene Knockout Cell Lines represents a valuable resource for advancing scientific inquiry and therapeutic development. These models not only enhance our understanding of gene function but also pave the way for innovative approaches in precision medicine.
Our company is dedicated to providing high-quality biological products backed by extensive research expertise, ensuring that our offerings, including the FAM168B Gene Knockout Cell Lines, meet the rigorous demands of the scientific community. Through our commitment to innovation and quality, we empower researchers to unlock new frontiers in biology and medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.